What's breaking now, across thousands of outlets.
One lawyer involved in the deal noted how it's yet another example of Paragon and key investor Fairmount — which have helped transform the once-unsavory reputation for reverse mergers — quickly executing on a complicated transaction.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
Debt marketed this week for an Anthropic-backed project in Norway shows lenders’ skittishness; high interest rates and a credit-rating provision.
The memory chipmaker has spent under $8 billion on buybacks since 2019. Its board just approved over four times that.
The war in Iran has cost the average American household $2,000 so far, according to estimates shared Monday by Mark Zandi, chief economist at Moody’s Analytics.
TORONTO — Roots Corporation (the “Company” or “Roots”) (TSX: ROOT) today announced that at its special meeting (the “Meeting”) of holders (the “Shareholders”) of common shares (the “Shares”) of Roots, Shareholders voted in favour of the special resolution (the “Arrangement Resolution”) approving the previously-announced plan of…
